Skip to content
Discover practical DIY guides, tool reviews, and renovation…

Social Media Content Creators Fueling Unofficial Market for Unapproved Weight-Loss Medication

An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Drug Acquiring Popularity Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where communities with thousands of members share comparison photos, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to users injecting products of unknown origin.

Some professionals stated the demand for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or prison.

Platform Response and Material Elimination

According to TikTok, the service has taken down violative content and banned associated hashtags and query recommendations. The organization stated it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of slimming results, positive reviews and step-by-step guides for preparing or injecting at residence.

After minutes of entering one community, a seller posted contact information, where the majority of transactions occur. The vendor provided an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Information and Costs

Inside these communities, messages show dark colored packages with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how long a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Although the science behind this drug is valid, these online products may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her team has already seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly significant medical dangers”.

The writer

Ruben Taylor

Elara is a seasoned DIY expert with over a decade of experience in home renovations and sustainable building practices.

Aurora Ladder Pro

Type to search articles.